Children's Hospital Boston
While the number of ASOs administered to patients with ultra-rare diseases has been steadily increasing, there are still uphill battles for their use.
Pfizer Turns to Health Social Network to Find Patients With Rare Lung Cancer Genetic Variants
Premium
The drugmaker has partnered with Inspire and others to find study participants who have a genetic resilience to lung cancer.